Bryant JL - Search Results

1

Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.

Pham LV, Bryant JL, Mendez R, Chen J, Tamayo AT, Xu-Monette ZY, Young KH, Manyam GC, Yang D, Medeiros LJ, Ford RJ. Pham LV, et al. Among authors: bryant jl. Oncotarget. 2016 Dec 6;7(49):80599-80611. doi: 10.18632/oncotarget.12413. Oncotarget. 2016. PMID: 27716624 Free PMC article.

2

Molecular imaging of mesothelioma with (99m)Tc-ECG and (68)Ga-ECG.

Zhang YH, Bryant J, Kong FL, Yu DF, Mendez R, Edmund Kim E, Yang DJ. Zhang YH, et al. J Biomed Biotechnol. 2012;2012:232863. doi: 10.1155/2012/232863. Epub 2012 May 8. J Biomed Biotechnol. 2012. PMID: 22645409 Free PMC article.

3

Molecular imaging kits for hexosamine biosynthetic pathway in oncology.

Yang DJ, Kong FL, Oka T, Bryant JL. Yang DJ, et al. Among authors: bryant jl. Curr Med Chem. 2012;19(20):3310-4. doi: 10.2174/092986712801215900. Curr Med Chem. 2012. PMID: 22664248 Review.

4

Development of intermediate-grade (mantle cell) and low-grade (small lymphocytic and marginal zone) human non-Hodgkin's lymphomas xenotransplanted in severe combined immunodeficiency mouse models.

Bryant J, Pham L, Yoshimura L, Tamayo A, Ordonez N, Ford RJ. Bryant J, et al. Lab Invest. 2000 Apr;80(4):557-73. doi: 10.1038/labinvest.3780061. Lab Invest. 2000. PMID: 10780672 Free article.

5

Assessment of cyclooxygense-2 expression with 99mTc-labeled celebrex.

Yang DJ, Bryant J, Chang JY, Mendez R, Oh CS, Yu DF, Ito M, Azhdarinia A, Kohanim S, Edmund Kim E, Lin E, Podoloff DA. Yang DJ, et al. Anticancer Drugs. 2004 Mar;15(3):255-63. doi: 10.1097/00001813-200403000-00010. Anticancer Drugs. 2004. PMID: 15014359

6

Assessment of therapeutic tumor response using 99mtc-ethylenedicysteine-glucosamine.

Yang D, Yukihiro M, Yu DF, Ito M, Oh CS, Kohanim S, Azhdarinia A, Kim CG, Bryant J, Kim EE, Podoloff D. Yang D, et al. Cancer Biother Radiopharm. 2004 Aug;19(4):443-56. doi: 10.1089/cbr.2004.19.443. Cancer Biother Radiopharm. 2004. PMID: 15453959

7

Regional radiochemotherapy using in situ hydrogel.

Azhdarinia A, Yang DJ, Yu DF, Mendez R, Oh C, Kohanim S, Bryant J, Kim EE. Azhdarinia A, et al. Pharm Res. 2005 May;22(5):776-83. doi: 10.1007/s11095-005-2594-7. Epub 2005 May 17. Pharm Res. 2005. PMID: 15906173

8

Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.

Yang DJ, Kim CG, Schechter NR, Azhdarinia A, Yu DF, Oh CS, Bryant JL, Won JJ, Kim EE, Podoloff DA. Yang DJ, et al. Among authors: bryant jl. Radiology. 2003 Feb;226(2):465-73. doi: 10.1148/radiol.2262011811. Radiology. 2003. PMID: 12563141

9

(99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals.

Yang DJ, Ozaki K, Oh CS, Azhdarinia A, Yang T, Ito M, Greenwell A, Bryant J, Kohanim S, Wong VK, Kim EE. Yang DJ, et al. Pharm Res. 2005 Sep;22(9):1471-9. doi: 10.1007/s11095-005-6157-8. Epub 2005 Aug 24. Pharm Res. 2005. PMID: 16132359

10

Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody.

Schechter NR, Yang DJ, Azhdarinia A, Kohanim S, Wendt R 3rd, Oh CS, Hu M, Yu DF, Bryant J, Ang KK, Forster KM, Kim EE, Podoloff DA. Schechter NR, et al. Anticancer Drugs. 2003 Jan;14(1):49-56. doi: 10.1097/00001813-200301000-00007. Anticancer Drugs. 2003. PMID: 12544258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters